These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cost considerations of analgesic therapy: an analysis of the effects of dosing frequency and route of administration. Goughnour BR Postgrad Med J; 1991; 67 Suppl 2():S87-91. PubMed ID: 1758824 [TBL] [Abstract][Full Text] [Related]
3. Control of severe pain with sustained-release morphine tablets v. oral morphine solution. Arkinstall WW; Goughnour BR; White JA; Stewart JH CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988 [TBL] [Abstract][Full Text] [Related]
4. Buprenorphine: a cost-effective alternative to Schedule II analgesics for moderate to severe pain relief. Rosenthal MH; Bayait F Hosp Formul; 1988 Jan; 23(1):57-60, 62, 71. PubMed ID: 10312332 [TBL] [Abstract][Full Text] [Related]
5. Effect of ethanol on the release of morphine sulfate from Oramorph SR tablets. Barkin RL; Shirazi D; Kinzler E Am J Ther; 2009; 16(6):482-6. PubMed ID: 19770796 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics. Reynolds RC; Ploetz P; Thielke TS Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974 [TBL] [Abstract][Full Text] [Related]
7. Microcost analysis of inpatient dispensing and administration of oral solids. Hatoum HT Am J Hosp Pharm; 1990 Apr; 47(4):800-5. PubMed ID: 2321657 [TBL] [Abstract][Full Text] [Related]
8. A cost comparison of intravenous cimetidine delivery systems. Jackson CW; Caldwell RD; Arford PD Hosp Pharm; 1990 Dec; 25(12):1085-9. PubMed ID: 10108250 [TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department. Miner JR; Moore J; Gray RO; Skinner L; Biros MH Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240 [TBL] [Abstract][Full Text] [Related]
10. Justification of a pharmacy intravenous admixture service in an Australian hospital. Plumridge RJ; Maher M Am J Hosp Pharm; 1993 Mar; 50(3):463-6. PubMed ID: 8442462 [TBL] [Abstract][Full Text] [Related]
11. Patient-controlled analgesia versus intramuscular analgesic therapy. Smythe M; Loughlin K; Schad RF; Lucarroti RL Am J Hosp Pharm; 1994 Jun; 51(11):1433-40. PubMed ID: 7942878 [TBL] [Abstract][Full Text] [Related]
13. Determining drug dispensing costs for use in cost-accounting systems. Thielke TS; Charlson JT; Heckethorn D Am J Hosp Pharm; 1988 Apr; 45(4):844-7. PubMed ID: 3376969 [TBL] [Abstract][Full Text] [Related]
14. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet. Freye E; Levy JV; Braun D Pain Pract; 2007 Dec; 7(4):324-31. PubMed ID: 17986159 [TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour single-container system for parenteral nutrient admixtures. Raebel MA; McDonald JB Am J Hosp Pharm; 1985 Jun; 42(6):1355-8. PubMed ID: 3925769 [TBL] [Abstract][Full Text] [Related]
16. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package. Kleinberg ML; Duafala ME Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222 [TBL] [Abstract][Full Text] [Related]
17. Personnel costs and preparation time in a centralized intravenous admixture program. Ryan DM; Daniels CE; Somani SM Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164 [TBL] [Abstract][Full Text] [Related]